세계의 페이스메이커 시장 보고서(2025년)
Pacemakers Global Market Report 2025
상품코드 : 1821591
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

페이스메이커 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.1%를 나타내 77억 6,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 원격의료, 공적·민간 헬스케어 투자, 소아·신생아 의료, 수술 기술, 소형화, 리드리스 디바이스 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향에는 인공지능(AI), 웨어러블 의료기술, 원격 프로그래밍, 전기생리학적 치료, 기술진보 등이 있습니다.

향후 5년간의 성장률 8.1%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 스위스와 독일에서 조달되는 페이스메이커의 비용을 상승시켜, 구명을 위한 심장 인터벤션을 늦추고, 순환기과의 지출을 높여 미국을 방해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

심혈관 질환의 발생률이 증가하면 향후 페이스메이커 시장 성장을 이끌 것입니다. 심혈관 질환에는 심장과 혈관에 영향을 미치는 질환이 포함됩니다. 이러한 질병에 대한 새로운 치료법을 확인하기 위해 신약 기술이 채택되었습니다. 심박 조율기는 유연한 절연 와이어로 구성되어 불규칙한 심장 리듬을 조정하여 심혈관 질환 관리를 지원합니다. 예를 들어, 2024년 1월 미국 비영리 단체인 미국 심장협회는 심혈관 질환으로 인한 연령 조정 사망률이 10만 명당 233.3명으로 전년 224.4명에서 4.0% 증가했다고 보고했습니다. 그 결과 심혈관 질환의 유병률 증가가 페이스메이커 시장을 밀어올릴 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Pacemakers are small devices implanted in the chest to regulate the heartbeat, specifically to prevent the heart from beating too slowly. They are utilized in the treatment of conditions such as fainting spells, congestive heart failure, and hypertrophic cardiomyopathy.

The main types of pacemakers include MRI-compatible pacemakers and conventional pacemakers. MRI-compatible pacemakers are devices that present no known hazards in specified MRI environments, subject to specific device and MRI scanner conditions. These pacemakers employ various technologies, such as single-chamber pacemakers, dual-chamber pacemakers, and biventricular or CRT (cardiac resynchronization therapy) pacemakers. They differ in implantability, with options including implantable pacemakers and external pacemakers. The applications of pacemakers encompass congestive heart failure, arrhythmias, bradycardia, and tachycardia, serving various end users such as hospitals, cardiac care centers, ambulatory surgical centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The pacemaker market research report is one of a series of new reports from The Business Research Company that provides pacemaker market statistics, including pacemaker industry global market size, regional shares, competitors with a pacemaker market share, detailed pacemaker market segments, market trends and opportunities, and any further data you may need to thrive in the pacemakers industry. This pacemaker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pacemakers market size has grown steadily in recent years. It will grow from $5.42 billion in 2024 to $5.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to aging population, cardiovascular diseases, lifestyle-related health issues, regulatory approvals, heart attack survivors.

The pacemakers market size is expected to see strong growth in the next few years. It will grow to $7.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to telemedicine, public and private healthcare investment, pediatric and neonatal care, surgical techniques, miniaturization and leadless devices. Major trends in the forecast period include artificial intelligence (AI), wearable health tech, remote programming, electrophysiology procedures, technological advancements.

The forecast of 8.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of pacemakers sourced from Switzerland and Germany, thereby delaying life-saving cardiac interventions and elevating cardiology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cardiovascular diseases is driving the growth of the pacemaker market in the future. Cardiovascular diseases encompass conditions that impact the heart and blood vessels. Drug discovery technologies are employed to identify new medications for these diseases. Pacemakers consist of flexible, insulated wires that assist in managing cardiovascular conditions by regulating irregular heart rhythms. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, representing a 4.0% rise from the previous year's rate of 224.4 per 100,000, following a 4.6% increase in 2023, marking the first rise in these rates seen in many years. Consequently, the growing prevalence of cardiovascular diseases is expected to boost the pacemaker market.

The expansion of the geriatric population is another factor expected to contribute to the growth of the pacemaker market. With age, the risk of heart conditions such as arrhythmias, atrial fibrillation, and bradycardia increases, necessitating pacemaker implantation. A report from the World Health Organization in October 2022 highlighted that by 2030, one in six people globally is expected to be 60 or older, with the global population of individuals aged 80 or older increasing by 426 million between 2020 and 2050. This demographic shift is a significant driver for the growth of the pacemaker market.

Innovation in product development is a notable trend in the pacemaker market, with major companies introducing novel products to cater to diverse customer needs and enhance revenue. For example, in July 2023, Abbott, a US-based medical device company, obtained FDA approval for the AVEIR dual chamber (DR) leadless pacemaker system. This innovative system, enabled by Abbott's i2i communication technology, facilitates synchronized cardiac pacing between two leadless pacemakers based on a patient's clinical requirements, expanding access to leadless pacing for a larger population in the United States.

Major companies in the pacemaker market are developing advanced products such as miniaturized pacemakers to further broaden their customer base and increase sales. In May 2023, Medtronic PLC, a US-based medical device company, received FDA approval for the Micra AV2 and Micra VR2, recognized as the world's smallest pacemakers. These miniaturized, leadless pacemakers offer extended battery life and simplified programming, aiming to reduce complications compared to traditional pacemakers. The Micra AV2 and Micra VR2 contribute to enhanced patient outcomes with their longer battery life and advanced algorithms for autonomous programming of atrioventricular synchrony.

In February 2023, Royal Philips, a health technology company based in the Netherlands, announced a long-term strategic partnership with TriHealth. This collaboration aims to incorporate Philips' extensive cardiology solutions into TriHealth's new Heart & Vascular Institute at Bethesda North Hospital and the Harold and Eugenia Thomas Comprehensive Care Center. The partnership is designed to enhance cardiac care services, meet community health commitments, coordinate health services among providers, and educate future healthcare professionals. TriHealth, a US-based organization, specializes in integrated healthcare delivery systems, including pacemakers.

Major companies operating in the pacemakers market include Boston Scientific Corporation, ZOLL Medical Corporation, Medtronic plc Biotronik Medical Devices India Pvt ltd., MicroPort Scientific Corporation, Cook Medical Incorporated, MEDICO S.p.A., Shree Pacetronix Ltd., Oscor Inc., Osypka Medical GmbH, Abbott Laboratories, LivaNova PLC, Lepu Medical Technology(Beijing)Co Ltd., Cordis Inc., Vitatron Holding B.V., Integer Holdings Corporation, Zoll Medical Corporation, Synapse Biomedical Inc., Pacetronix Limited, Sorin Group Italia S.r.l., Galix Biomedical Instrumentation Inc., Imricor Medical Systems Inc., Sterimed Group, Edwards Lifesciences Corporation, SMT Medical GmbH & Co. KG, Spacelabs Healthcare Inc., BioTrace Medical Inc.

North America was the largest region in the pacemaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pacemaker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The pacemaker market consists of sales of leadless pacemakers and transvenous peacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pacemakers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pacemakers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pacemakers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pacemakers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Pacemakers Market Characteristics

3. Pacemakers Market Trends And Strategies

4. Pacemakers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pacemakers Growth Analysis And Strategic Analysis Framework

6. Pacemakers Market Segmentation

7. Pacemakers Market Regional And Country Analysis

8. Asia-Pacific Pacemakers Market

9. China Pacemakers Market

10. India Pacemakers Market

11. Japan Pacemakers Market

12. Australia Pacemakers Market

13. Indonesia Pacemakers Market

14. South Korea Pacemakers Market

15. Western Europe Pacemakers Market

16. UK Pacemakers Market

17. Germany Pacemakers Market

18. France Pacemakers Market

19. Italy Pacemakers Market

20. Spain Pacemakers Market

21. Eastern Europe Pacemakers Market

22. Russia Pacemakers Market

23. North America Pacemakers Market

24. USA Pacemakers Market

25. Canada Pacemakers Market

26. South America Pacemakers Market

27. Brazil Pacemakers Market

28. Middle East Pacemakers Market

29. Africa Pacemakers Market

30. Pacemakers Market Competitive Landscape And Company Profiles

31. Pacemakers Market Other Major And Innovative Companies

32. Global Pacemakers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pacemakers Market

34. Recent Developments In The Pacemakers Market

35. Pacemakers Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기